Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 16, 2017
LYSOGENE REINFORCES ITS MANAGEMENT TEAM WITH THE NOMINATION OF PHILIPPE MENDELS-FLANDRE AS CHIEF OPERATING OFFICER
Lysogene (FR0013233475 – LYS), a leading clinical-stage biopharmaceutical company specializing in gene therapy technology applied to central nervous system diseases, today announced the nomination of ...
May 16, 2017
Rockwell Medical Encourages Shareholders Not to Be Misled by Richmond Brothers
WIXOM, Mich., May 16, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI) today mailed a letter to its shareholders in connection with the Company’s upcoming ...
May 16, 2017
Aeglea BioTherapeutics to Present at the UBS 2017 Global Healthcare Conference
AUSTIN, Texas, May 16, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (AGLE) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino ...
May 16, 2017
Prothena Announces Appointment of Sarah Noonberg, MD, PhD as Chief Medical Officer
DUBLIN, Ireland, May 16, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of ...
May 16, 2017
BioDelivery Sciences Reports First Quarter 2017 Financial Results and Provides Corporate Update
RALEIGH, N.C., May 15, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the first quarter ended March 31, 2017 and ...
May 16, 2017
OSE Immunotherapeutics Presents New Data on Anti-SIRPa (Effi-DEM), the Checkpoint Inhibitor blocking Pro-Tumor and Suppressor Myeloid Cells at “Advances in Immuno-Oncology Congress,” London, May 15-16, 2017
NANTES, France, May 15, 2017 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA(ISIN:FR0012127173) (Mnémo:OSE) announced today that the Company presented in oral session significant data on Selective ...
May 16, 2017
LifeSci Venture Partners’ Paul Yook to Moderate Panel at MedCity INVEST Conference
NEW YORK, May 15, 2017 (GLOBE NEWSWIRE) -- LifeSci Advisors today announced that Paul Yook, General Partner, LifeSci Venture Partners, will moderate the opening panel ...
May 16, 2017
Pernix Therapeutics Reports First Quarter 2017 Financial Results and Provides Business Update
MORRISTOWN, N.J., May 15, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced financial results ...
May 16, 2017
Windtree Therapeutics Reports First Quarter 2017 Financial Results and Provides Key Business Updates
WARRINGTON, Pa., May 15, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported ...
May 16, 2017
Threshold Pharmaceuticals Reports First Quarter Financial Results
MENLO PARK, Calif., May 15, 2017 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (THLD) today reported financial results for the first quarter ended March 31, 2017, ...
May 16, 2017
Santhera to Present Data and Host Symposium on Pulmonary Function in Duchenne Muscular Dystrophy at the American Thoracic Society 113th Annual Conference
Liestal, Switzerland, May 16, 2017 - Santhera Pharmaceuticals, a specialty pharmaceutical company focused on the development of innovative treatments for rare mitochondrial and neuromuscular diseases, announces ...
May 16, 2017
BrainStorm Initiated Technology Transfer to City of Hope for U.S. Production of NurOwn® for Phase 3 ALS Study
HACKENSACK, N.J., PETACH TIKVA, Israel and DUARTE, Calif., May 16, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies ...
May 16, 2017
Kamada Reports 2017 First Quarter Financial Results
NESS ZIONA, Israel, May 16, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd.  (KMDA) (KMDA.TA), a plasma-derived protein therapeutics company focused on orphan indications, today announced financial ...
May 16, 2017
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on May 16, 2017
CRANBURY, N.J., May 16, 2017 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases ...
May 16, 2017
Altimmune Promotes Dr. Sybil Tasker to Chief Medical Officer
GAITHERSBURG, Md., May 16, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced the promotion of Sybil Tasker, M.D., FACP, FIDSA, ...
May 16, 2017
Albireo Announces Two New U.S. Patents Allowed for A4250 with Term into 2031
BOSTON, May 16, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
May 16, 2017
CTD Holdings to Host Webinar to Provide Update on Trappsol(R) Cyclo(TM) Drug Development Program for Treatment of Niemann-Pick Disease Type C
ALACHUA, FL--(Marketwired - May 16, 2017) - CTD Holdings, Inc. (CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, ...
May 15, 2017
INNATE PHARMA : First quarter 2017 report
Marseille, France, May 15, 2017, 7:00 AM CEST -- Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announced its revenues and cash ...
May 15, 2017
Ignyta Granted Breakthrough Therapy Designation for Entrectinib by U.S. Food and Drug Administration
SAN DIEGO--(BUSINESS WIRE)-- Ignyta, Inc. (RXDX), a biotechnology company focused on precision medicine in oncology, today announced that the U.S. Food and Drug Administration (FDA) has ...
May 15, 2017
Aradigm Announces First Quarter 2017 Financial Results
Aradigm Corporation (ARDM) (the “Company”) today announced financial results for the first quarter and three months ended March 31, 2017. ...
Page 148 of 153